Because HMGA1 may not only serve as a prognostic marker but may also be causally involved in metastatic progression, and because HMGA1 is not present in most adult normal tissues [20], [21], it may become an attractive target for cancer therapy [25], [48]. This evidence concerns the gene HMGA1 and cancer.